Aidoc vs DeepHealth
Aidoc and DeepHealth both compete in radiology, but answer different questions. Aidoc is our pick for acute-care triage: Most-deployed acute-care triage AI in US hospitals (1,000+ sites). DeepHealth earns the global radiology AI portfolio slot: World's largest after Gleamer acquisition (March 2026). The right choice depends on whether your priority is acute-care triage or global radiology ai portfolio.
- Radiology
- 02
- October 20, 2026
Aidoc
by Aidoc · founded 2016
Clinical AI platform (aiOS) with FDA-cleared triage, notification and quantification algorithms for radiology and neurovascular care.
- Private offer only. No trial is stated.
- FDA 510(k) (multiple) / EU MDR 2017/745 / ISO 13485:2016
DeepHealth
by RadNet / DeepHealth, Inc.
Imaging AI from RadNet's DeepHealth: mammography (Saige-Dx, Saige-Density), breast arterial calcification, prostate, lung, bone and chest X-ray.
- No public price. The homepage shows none.
- FDA 510(k) (multiple) / CE Mark (Mia, 2019, per DeepHealth page)
How Aidoc and DeepHealth compare
Pricing, compliance, and integrations sourced from vendor documentation. Verified October 20, 2026.
| Spec | Aidoc | DeepHealth |
|---|---|---|
| Pricing | Private offer only. No trial is stated. | No public price. The homepage shows none. |
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | 2016 | — |
| HQ | IL | US |
| Best for | Best for acute-care triage | Best global radiology AI portfolio |
Scroll horizontally to see both columns.
When to pick each one
Best for acute-care triage
Most-deployed acute-care triage AI in US hospitals (1,000+ sites).
- 31+ FDA clearances across stroke, PE, ICH, C-spine
- Foundation model CARE1 across modalities
Best global radiology AI portfolio
World's largest after Gleamer acquisition (March 2026).
- RadNet-owned
- CXR, mammography, CT, MRI
- ~$140M ARR projected EOY 2026
- Spans CV + onc + neuro
Other head-to-heads worth reading
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.